Elitech
Who owns Elitech?
Elitech is a French MedTech company, now owned by Bruker, which acquired it in 2024 from PAI Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BYKey facts
- ·Fully exited in 2024 to Bruker Corporation.
- ·Average hold across 3 realized cycles: 9 years.
Ownership history
3 ownership periods · co-invest detected
Naxicap Partners sold ELITECH to PAI Partners in 2017 after 7 years.
Apheon sold ELITech to Bruker in 2023 after 13 years.
PAI Partners sold ELITECH to Bruker in 2024 after 7 years.
More from PAI Europe VI
Other portfolio companies in the same fund.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns Elitech?
Elitech is now owned by Bruker, which acquired it in 2024 from PAI Partners.
When did Bruker acquire Elitech?
Bruker acquired Elitech in 2024, buying from PAI Partners.
Who did Elitech sell to?
PAI Partners sold Elitech to Bruker in 2024 (Trade Sale). Apheon sold Elitech to Bruker in 2023 (Trade Sale). Naxicap Partners sold Elitech to PAI Partners in 2017 (Secondary).
Who has owned Elitech over time?
Elitech has been through 3 private-equity ownership periods: Naxicap Partners · via Naxicap Legacy Funds · 2010–2017 · sold to PAI Partners · (Secondary); Apheon · via AMB II · 2010–2023 · sold to Bruker · (Trade Sale); PAI Partners · via PAI Europe VI · 2017–2024 · sold to Bruker · (Trade Sale).